Progressive degradation of serum samples limits proteomic biomarker discovery

被引:18
作者
Ahmad, Shadab [1 ]
Sundaramoorthy, Elayanambi [1 ]
Arora, Reena [2 ]
Sen, Somdutta [2 ]
Karthikeyan, Ganesan [3 ]
Sengupta, Shantanu [1 ]
机构
[1] Inst Genom & Integrat Biol, Dept Prote & Struct Biol, New Delhi 110007, India
[2] Ctr Genom Applicat, New Delhi 110020, India
[3] All India Inst Med Sci, Dept Cardiol, New Delhi 110029, India
关键词
Biomarker; Sample aging; Magnetic bead profiling; Mass spectrometry; MALDI; Peptidomics; Proteomics; Serum profiling;
D O I
10.1016/j.ab.2009.07.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Preanalytical variables play a key role in discovery of biomarkers. Although the effect of several preanalytical variables on the mass spectral profiles has been studied extensively, little is known about long-term storage of serum samples. This is important because samples used in case-control or epidemiological studies are usually stored for a long time before analysis. Here we evaluated long-term storage effects on mass spectral peak patterns of serum peptides extracted using weak cation exchange magnetic beads. For this, 20 serum samples stored at -80 degrees C were divided equally into two groups based on their storage time. We found that intensities of 26 mass spectral peaks significantly varied between these two groups. Intensities of these peaks significantly correlated with storage time. Genetic algorithm-based models generated using these 26 peaks could classify 63 additional samples into these two groups with 100% and 96% accuracy, respectively. We also show that storing samples for 10 months at -80 and -20 degrees C results in the appearance/disappearance or intensity variation of peaks, some of which were previously reported as disease biomarkers. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 12 条
[1]   Reproducibility in protein profiling by MALDI-TOF mass spectrometry [J].
Albrethsen, Jakob .
CLINICAL CHEMISTRY, 2007, 53 (05) :852-858
[2]   Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry [J].
de Noo, ME ;
Tollenaar, RAEM ;
Özalp, A ;
Kuppen, PJK ;
Bladergroen, MR ;
Eilers, PHC ;
Deelder, AM .
ANALYTICAL CHEMISTRY, 2005, 77 (22) :7232-7241
[3]   Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling [J].
Hsieh, Sen-Yung ;
Chen, Ren-Kung ;
Pan, Yi-Hsin ;
Lee, Hai-Lun .
PROTEOMICS, 2006, 6 (10) :3189-3198
[4]  
Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322
[5]   Proteomics in cardiovascular biology and medicine [J].
Loscalzo, J .
CIRCULATION, 2003, 108 (04) :380-383
[6]   Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction [J].
Marshall, J ;
Kupchak, P ;
Zhu, WM ;
Yantha, J ;
Vrees, T ;
Furesz, S ;
Jacks, K ;
Smith, C ;
Kireeva, I ;
Zhang, R ;
Takahashi, M ;
Stanton, E ;
Jackowski, G .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (04) :361-372
[7]   Are multiple markers the future of prostate cancer diagnostics? [J].
Mikolajczyk, SD ;
Song, Y ;
Wong, JR ;
Matson, RS ;
Rittenhouse, HG .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :519-528
[8]  
NORAGER MW, 2007, J CHROMATOGR B, V847, P30
[9]   Use of proteomic patterns in serum to identify ovarian cancer [J].
Petricoin, EF ;
Ardekani, AM ;
Hitt, BA ;
Levine, PJ ;
Fusaro, VA ;
Steinberg, SM ;
Mills, GB ;
Simone, C ;
Fishman, DA ;
Kohn, EC ;
Liotta, LA .
LANCET, 2002, 359 (9306) :572-577
[10]   Differential exoprotease activities confer tumor-specific serum peptidome patterns [J].
Villanueva, J ;
Shaffer, DR ;
Philip, J ;
Chaparro, CA ;
Erdjument-Bromage, H ;
Olshen, AB ;
Fleisher, M ;
Lilja, H ;
Brogi, E ;
Boyd, J ;
Sanchez-Carbayo, M ;
Holland, EC ;
Cordon-Cardo, C ;
Scher, HI ;
Tempst, P .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :271-284